Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-02-01 @ 7:39 PM
Study NCT ID:
NCT02172950
Status:
COMPLETED
Last Update Posted:
2021-10-27
First Post:
2014-06-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Sponsor:
CSL Behring
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSL627_3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None